Latest News for DSRLF
DiaSorin (OTCMKTS:DSRLF - Get Free Report) and Perrigo (NYSE: PRGO - Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Analyst Ratings This is a summary of current ratings and
DiaSorin S.p.A. (DSRLF) Q4 2025 Earnings Call Transcript
DiaSorin (OTCMKTS:DSRLF - Get Free Report) and Abbott Laboratories (NYSE: ABT - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Risk and Volatility DiaSorin has a beta of 0.1,
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for DSRLF.
Senate Trading
No Senate trades found for DSRLF.
U.S. House Trading
No House trades found for DSRLF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.